Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
News
2016/04/26 – Regulatory authorisations received in France to begin Phase IIa multicentric European trial for heart failure
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/04/14 – 2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/03/24 – Quantum Genomics raises €8.6 Million in U.S. and Europe
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/03/17 – Quantum Genomics raises €5.54m via private placement in the United States and launches a capital increase amounting to €2.94m
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/02/03 – Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/01/20 – Enhancement of Quantum Genomics’ intellectual property : new patent approved for the United States
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2016/01/05 – Patient enrolment 100% completed for Phase IIa trial for high blood pressure
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/12/16 – Further advance for Quantum Genomics in securing animal health partnership for heart failure treatment
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…
2015/11/25 – Quantum Genomics’ Scientific Advisory Board recommends next multicentric clinical trials in Europe and United States
Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new…